Neuroprotective efficacy of the peroxisome proliferator-activated receptor -selective agonists in vitro and in vivo
Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes
Vardiyan R, Ezati D, Anvari M, Ghasemi N, Talebi AJC, Medicine ER
Pharmaceutics 13 , 15991607 (2016)
Potential Side Effects While GLP-1 medications are generally well-tolerated, potential side effects include: Nausea Diarrhea Vomiting Constipation Abdominal pain Most side effects are mild and improve with continued use
Supplements GLOTAMIN ENTOD BEAUTY 10 TABS Clinical Efficacy Markers Glutathione Astaxanthin Alpha Lipoic Acid The Science of Supplements ENTOD BEAUTY GLOTAMIN (10 TABS) Drug Facts Glutathione, Astaxanthin, Alpha Lipoic Acid, Co Enzyme Q10, Resveratrol, Grape Seed Extract with Vitamin A & Vitamin C Tablets